Bothell based BioLife Solutions, Inc. today announced its participation at the Terrapinn World Stem Cells and Regenerative Medicine Congress 2013 this week in London.

BioLife’s Senior Vice President and Chief Technology Officer, Dr. Aby J. Mathew, will make a presentation titled “Critical Stability and Biopreservation Considerations for Manufacturing, Storage and Clinical Delivery of Cell and Tissue Products,” to the audience of executives and

product development managers of commercial regenerative medicine companies.

The presentation outlines the risk to clinical and commercial success of cell and tissue products due to stability limitations from the use of non-optimized storage, transport and cryopreservation freeze media.

Comparative data illustrating the superior preservation efficacy of BioLife’s HypoThermosol storage and shipping media, and CryoStor cryopreservation freeze media will be presented on relevant cell and tissue types.

“We continue to build traction in the high growth regenerative medicine market, and estimate that more than 65 percent of the presenting companies at this conference have adopted our best in class, clinical grade biopreservation media products,” Chief Executive Officer Mike Rice said. “A key value-added service we provide, which directly translates into expanded product adoption, is the high quality consulting our team offers to prospective and current customers. Biopreservation outcomes such as cell and tissue shelf life, viability and recovery can greatly impact commercial potential. The combination of the efficacy and quality of our proprietary platform technology, along with our expert technical consulting services, is now recognized and highly valued in the development and commercialization of regenerative medicine products and therapies.”

The regenerative medicine market is expected to grow to more than $35 billion by 2019, according to TriMark Publications’ recently published “Regenerative Medicine Markets” report.

BioLife’s addressable portion of the market is the demand for reagents used to store, ship and freeze source material and manufactured doses of cell-based products and therapies.

BioLife Solutions is a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer.